Florian Lordick/LinkedIn
May 1, 2025, 00:45
Florian Lordick: Latest Real World Data on Biomarker Testing for Patients with Gastric Cancer
Florian Lordick, Professor of Medicine at the University of Leipzig, shared a post on LinkedIn:
“Happy to share latest Real World Data on Biomarker testing for patients with Gastric Cancer in clinical routine and in the Leipzig Pathology. Results of the Saphir Study, published by Karin Potthoff et al. in ESMO – European Society for Medical Oncology Real World Data and Digital Oncology journal.”
“Local and central testing for HER2, PD-L1, MSI/MMR, EBV, and CLDN18.2 in advanced gastric cancer: results from the SAPHIR registry”
Authors: K. Potthoff, H. Bläker, T. Dechow, A. Binninger, K. Ringwald, R. de Buhr, E. von der Heyde, M.-O. Zahn, A. Nusch, S. Dörfel, H. Schulz, I. Haffner, A.K. Höhn, A. Monecke, S. Lorenzen, A. Reinacher-Schick, M. Jänicke, F. Lordick
You Can Read the Full Article in Real World Data and Digital Oncology journal.
More posts featuring Florian Lordick.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 1, 2025, 15:20
May 1, 2025, 14:51
May 1, 2025, 14:30
May 1, 2025, 14:00
May 1, 2025, 13:26
May 1, 2025, 13:03